# Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial

Study · id `cardio:ct-nct07397845` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07397845](<https://clinicaltrials.gov/study/NCT07397845>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07397845

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1380 participants.

## Technical summary

Registry record NCT07397845. Randomized; no masking; primary purpose treatment. Start 2026-04-22 (actual); primary completion 2028-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1380 participants (planned count; ClinicalTrials.gov record NCT07397845, source copy `cardio:ctgov-nct07397845-2026-06-01`, retrieved 2026-10-26)
- Started: 2026-04-22 (actual) (ClinicalTrials.gov record NCT07397845, source copy `cardio:ctgov-nct07397845-2026-06-01`, retrieved 2026-10-26)
- Primary completion: 2028-04 (anticipated) (ClinicalTrials.gov record NCT07397845, source copy `cardio:ctgov-nct07397845-2026-06-01`, retrieved 2026-10-26)
- Completion: 2029-04 (anticipated) (ClinicalTrials.gov record NCT07397845, source copy `cardio:ctgov-nct07397845-2026-06-01`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT07397845, source copy `cardio:ctgov-nct07397845-2026-06-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07397845-2026-06-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial
- Acronym: SPARX RCT
- Condition: Coronary Artery Disease
- Condition: Drug Eluting Balloon
- Condition: Drug Eluting Stent
- Intervention (Device): Protégé and Protégé NC
- Intervention (Device): Agent
- Intervention (Device): Drug Eluting Stent
- Lead sponsor: Translumina GmbH
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: f8fe537e4327dd44ee0e0d510edf16e6308f23604874e07e0e3f1040aebdd502
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
